Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A simple blood test to predict who will develop Alzheimer’s disease could be the ace up science’s sleeve when it comes to defeating dementia, says Simon Lovestone, professor of translational neuroscience at Oxford University.

Professor Simon Lovestone, from the Department of Psychiatry is interviewed by The Telegraph in their campaign to raise awareness around dementia.

Read the following extract:

'After 10 years of research, the professor – also a Lead Academic Scientist at the Alzheimer’s Research UK-funded Oxford Drug Discovery Institute – and his team have identified a combination of 10 proteins which can give early warning of Alzheimer’s, with an accuracy of 87 per cent.

Read more (Department of Psychiatry website)

Similar stories

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Daily contact COVID-19 testing for students effective at controlling transmission in schools

A study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.